The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy
Abstract
Developed by the Task Force on Blood Component Therapy: Linda C. Stehling, MD, (Chair), Scottsdale, Arizona; Dennis C. Doherty, D.O., Atlanta, Georgia; Ronald J. Faust, MD, Rochester, Minnesota; A. Gerson Greenburg, MD, Ph.D. (Representative, American College of Surgeons), Providence, Rhode Island; Chantal R. Harrison, MD (Representative, College of American Pathologists), San Antonio, Texas; Dennis F. Landers, MD, Dallas, Texas; Russell K. Laros, Jr., MD (Representative, American College of Obstetricians and Gynecologists), San Francisco, California; Ellison C. Pierce, Jr., MD, Boston, Massachusetts; Randall S. Prust, MD, Tucson, Arizona; Andrew D. Rosenberg, MD, New York, New York; Richard B. Weiskopf, MD, San Francisco, California; Steven H. Woolf, MD, M.P.H. (Methodologist), Fairfax, Virginia; and John F. Zeiger, MD, Ft. Wayne, Indiana.Submitted for publication November 1, 1995. Accepted for publication November 7, 1995. Supported by the American Society of Anesthesiologists, under the direction of James F. Arens, MD, Chairman of the Committee on Practice Parameters. Approved by the House of Delegates, October 25, 1995.Address correspondence to Dr. Stehling: 6210 East Oak Street, Scottsdale, Arizona, 85252–1867.Address reprint requests to the American Society of Anesthesiologists: 520 North Northwest Highway, Park Ridge, Illinois 60068–2573.MORE than 22 million blood components are transfused each year in the United States. [1]Many of these transfusions are administered to surgical and obstetric patients. The transfusion of red blood cells (RBCs), platelets, fresh-frozen plasma (FFP), and cryoprecipitate has the potential of improving clinical outcomes in perioperative and peripartum settings. These benefits include improved tissue oxygenation and decreased bleeding. However, transfusions are not without risks or costs. The transmission of infectious diseases (e.g., hepatitis, human immunodeficiency virus (HIV) infection), hemolytic and nonhemolytic transfusion reactions, immunosuppression, alloimmunization, and other complications are potential sequelae of blood component therapy.A number of groups have issued clinical practice guidelines for blood component therapy in an effort to improve transfusion practices, minimize the incidence of adverse transfusion reactions, and decrease costs. In the 1980s, the National Institutes of Health convened consensus conferences and published recommendations for RBC transfusion, platelet therapy, and the administration of FFP. [2–4]In 1984, the American College of Obstetricians and Gynecologists (ACOG) issued recommendations on blood component therapy. [5]In 1990, the Transfusion Practices Committee of the American Association of Blood Banks issued guidelines for transfusion of patients undergoing coronary artery bypass surgery. [6]In 1992, the American College of Physicians (ACP) issued recommendations for RBC transfusion. [7]In 1994, the College of American Pathologists (CAP) published a practice parameter for FFP, cryoprecipitate, and platelet transfusion. [8]Guidelines for blood utilization review were published in the same year by the American Association of Blood Banks. [9]Although these documents include sections on the use of blood components in the surgical setting, no group has issued current and comprehensive recommendations on perioperative and peripartum blood component therapy.In 1994, the American Society of Anesthesiologists convened the Task Force on Blood Component Therapy to develop evidence-based guidelines on the proper indications for perioperative and peripartum administration of RBCs, platelets, FFP, and cryoprecipitate. The task force included nine anesthesiologists (in private and university-based practice); one physician representative from the American College of Surgeons, College of American Pathologists, and ACOG; and a methodologist.Before the guidelines were developed, the task force reviewed published evidence regarding the clinical effectiveness of perioperative and peripartum blood component therapy. A total of 1,417 articles were retrieved in a computerized and manual literature search conducted in mid-1994. The computerized search sought all English-language literature published in any country on the use of RBCs, platelets, FFP, or cryoprecipitate in the perioperative or peripartum setting. A total of 160 articles were considered relevant. Published evidence was considered relevant if it addressed the perioperative or peripartum use of the above blood components and measured effectiveness in terms of clinical outcomes. The strength of evidence was classified by study design category, using the scale in Table 1. Further details about the literature review methodology are available on request. Input from practicing anesthesiologists was obtained at an open forum held in October 1994. The document was sent to members of the American Society of Anesthesiologists House of Delegates, Board of Directors, and Component Society Presidents
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients.
JONSSON, K., JENSEN, J. A., GOODSON, W. H., SCHEUENSTUHL, H., WEST, J., HOPF, H. W., & HUNT, T. K. (1991) · Annals of Surgery · doi:10.1097/00000658-199111000-00011 · Cited by 462
Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery
Goodnough, L. T., Soegiarso, R. W., Birkmeyer, J. D., & Welch, H. G. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90086-5 · Cited by 129
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
Carson, J. L., Grossman, B. J., Kleinman, S., Tinmouth, A. T., Marques, M. B., Fung, M. K., Holcomb, J. B., Illoh, O., Kaplan, L. J., Katz, L. M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-1-201206190-00429 · Cited by 1,084
Metadata
- Venue
- Anesthesiology
- Published
- 1996-03-01
- Volume
- 84
- Issue
- 3
- Pages
- 732-747
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W4293915724
- Cited by
- 755
- References
- 2
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. https://app.cochat.ai/papers/10.1097/00000542-199603000-00032
- The paper
- Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. (1996). Anesthesiology. https://doi.org/10.1097/00000542-199603000-00032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.